National security challenge: China poised to overtake the U.S. as the global leader in biotechnology innovation

The comprehensive report from the bipartisan National Security Commission on Emerging Biotechnology (NSCEB) delivers a “sobering, even frightening,” conclusion: that China is quickly ascending to biotechnology dominance, having made biotechnology a strategic priority for 20 years. To remain competitive, the report asserts, the United States must take swift action in the next three years. “Otherwise, we risk falling behind, a setback from which we may never recover.”

Biotechnology, particularly when powered by AI, can revolutionize critical sectors, from defense and energy to agriculture and manufacturing. … [I]f the United States fails to act, the commission warns, biotechnology could also expose vulnerabilities in infrastructure, disrupt supply chains, and contribute to food crises.

…

Share this article

XLinkedInFacebookRedditBlueskyThreadsSMSEmail

The report describes how China’s approach to biotechnology mirrors its broader strategy for technology and defense leadership—first, it acquires intellectual property from abroad, legally or illegally. Then, state-backed entities scale up these innovations and pump capital into domestic biotech firms to corner and eventually overwhelm global supply chains with low-cost products.

This is an excerpt. Read the original post here